{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:36:55Z","timestamp":1793137015572,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.jjcc.2014.02.022","type":"journal-article","created":{"date-parts":[[2014,4,13]],"date-time":"2014-04-13T12:03:08Z","timestamp":1397390588000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Advances in medical treatment of hypertrophic cardiomyopathy"],"prefix":"10.1016","volume":"64","author":[{"given":"Mareomi","family":"Hamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuntaro","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Shigematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2014.02.022_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/hrt.20.1.1","article-title":"Asymmetrical hypertrophy of the heart in young adults","volume":"20","author":"Teare","year":"1958","journal-title":"Br Heart J"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0010","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1106468","article-title":"Cardiac arrest during long-distance running races","volume":"366","author":"Kim","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy","volume":"348","author":"Maron","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0020","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJM198210143071607","article-title":"Muscular subaortic stenosis: hemodynamic and clinical improvement after disopyramide","volume":"307","author":"Pollick","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0025","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/0002-9149(88)90553-X","article-title":"Oral disopyramide therapy for obstructive hypertrophic cardiomyopathy","volume":"62","author":"Sherrid","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0030","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1161\/01.CIR.96.5.1520","article-title":"Class Ia antiarrhythmic drug cibenzoline: a new approach to the medical treatment of hypertrophic obstructive cardiomyopathy","volume":"96","author":"Hamada","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0035","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1253\/circj.69.940","article-title":"Antiarrhythmic drug cibenzoline attenuates left ventricular pressure gradient and improves transmitral Doppler flow pattern in patients with hypertrophic obstructive cardiomyopathy caused by midventricular obstruction","volume":"69","author":"Hamada","year":"2005","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0040","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00005344-199002000-00019","article-title":"Comparison of anticholinergic effects of cibenzoline, disopyramide, and atropine","volume":"15","author":"Cazes","year":"1990","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0045","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1253\/jcj.65.531","article-title":"Antiarrhythmic drug, cibenzoline, can directly improve the left ventricular diastolic function in patients with hypertrophic cardiomyopathy","volume":"65","author":"Hamada","year":"2001","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0050","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/0002-9149(84)90643-X","article-title":"Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography","volume":"53","author":"Maron","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0055","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0735-1097(93)90054-5","article-title":"Coexistence of sudden cardiac death and end-stage heart failure in familial hypertrophic cardiomyopathy","volume":"22","author":"Hecht","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0060","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1161\/01.CIR.65.7.1388","article-title":"Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients","volume":"65","author":"Maron","year":"1982","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0065","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/0002-9149(81)90535-X","article-title":"Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features","volume":"47","author":"McKenna","year":"1981","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0070","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0002-9149(78)90870-6","article-title":"Malignant hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death","volume":"41","author":"Maron","year":"1978","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0075","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0002-9149(81)90604-4","article-title":"Prognostic significance of 24-hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study","volume":"48","author":"Maron","year":"1981","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0080","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/0002-8703(79)90012-7","article-title":"Progression to left ventricular dilatation in patients with hypertrophic obstructive cardiomyopathy","volume":"97","author":"ten Cate","year":"1979","journal-title":"Am Heart J"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0085","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/0002-9149(79)90139-5","article-title":"Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries","volume":"43","author":"Maron","year":"1979","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0090","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1253\/jcj.48.1210","article-title":"Progression from hypertrophic obstructive cardiomyopathy to typical dilated cardiomyopathy-like features in the end stage","volume":"48","author":"Fujiwara","year":"1984","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0095","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0002-8703(85)90561-7","article-title":"Three autopsy cases of progression to left ventricular dilatation in patients with hypertrophic cardiomyopathy","volume":"109","author":"Yutani","year":"1985","journal-title":"Am Heart J"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0002-9149(87)90998-2","article-title":"Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy","volume":"60","author":"Spirito","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0105","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1253\/jcj.54.354","article-title":"Persistent elevation of cardiac enzymes in a patient with hypertrophic cardiomyopathy: with special reference to electrocardiographic, echocardiographic and 201-thallium myocardial scintigraphic findings","volume":"54","author":"Hamada","year":"1990","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0110","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2169\/naika.82.188","article-title":"From typical hypertrophic cardiomyopathy to dilated cardiomyopathy-like features","volume":"82","author":"Hamada","year":"1993","journal-title":"J Jpn Soc Intern Med"},{"issue":"Suppl. I","key":"10.1016\/j.jjcc.2014.02.022_bib0115","article-title":"Transition from typical hypertrophic cardiomyopathy to end-stage congestive heart failure: 12-year follow-up study in 210 patients","volume":"96","author":"Hamada","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0120","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jacc.2005.04.062","article-title":"Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients","volume":"46","author":"Biagini","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0125","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/CIRCULATIONAHA.105.583500","article-title":"Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy","volume":"114","author":"Harris","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0130","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0092-8674(01)00242-2","article-title":"The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms","volume":"104","author":"Seidman","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0135","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1172\/JCI200317612","article-title":"Genotype, phenotype: upstairs, downstairs in the family of cardiomyopathies","volume":"111","author":"Chien","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0140","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0735-1097(02)02957-1","article-title":"A novel missence mutation in the myosin binding protein-C gene is responsible for hypertrophic cardiomyopathy with left ventricular dysfunction and dilation in elderly patients","volume":"41","author":"Konno","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0145","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/0002-8703(85)90358-8","article-title":"Thallium perfusion and cardiac enzyme abnormalities in patients with familial hypertrophic cardiomyopathy","volume":"109","author":"Nagata","year":"1985","journal-title":"Am Heart J"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0150","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1161\/01.CIR.74.1.105","article-title":"Diagnostic changes in plasma creatine kinase isoforms early after the onset of acute myocardial infarction","volume":"74","author":"Jaffe","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0155","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1042\/cs0810723","article-title":"Serum creatine kinase MM isoforms in hypertrophic cardiomyopathy","volume":"81","author":"Hamada","year":"1991","journal-title":"Clin Sci"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0160","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.jacc.2013.03.055","article-title":"Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy","volume":"62","author":"Kubo","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0165","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jjcc.2013.07.008","article-title":"Prevalence and determinants of elevated high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy","volume":"63","author":"Jenab","year":"2014","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jjcc.2013.10.005","article-title":"Subendocardial ischemia in hypertrophic cardiomyopathy","volume":"63","author":"Kawasaki","year":"2014","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0175","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1042\/cs0880551","article-title":"Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischemia induced by dynamic exercise in patients with angina pectoris","volume":"88","author":"Marumoto","year":"1995","journal-title":"Clin Sci"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0180","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1253\/jcj.59.715","article-title":"Augmented secretion of atrial and brain natriuretic peptides during dynamic exercise in patients with old myocardial infarction","volume":"59","author":"Marumoto","year":"1995","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0185","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/cs0940021","article-title":"Increased plasma levels of adrenomedullin in patients with hypertrophic cardiomyopathy: its relation to endothelin-1, natriuretic peptides and noradrenaline","volume":"94","author":"Hamada","year":"1998","journal-title":"Clin Sci"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0190","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1161\/01.CIR.90.4.1786","article-title":"Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy","volume":"90","author":"Levy","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0195","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1161\/CIRCULATIONAHA.105.595892","article-title":"Significance of a fragmented QRS complex versus a Q wave in patients with coronary artery disease","volume":"113","author":"Das","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0200","first-page":"459","article-title":"Clinical evaluation of cardiomyopathies","volume":"61","author":"Hamada","year":"2007","journal-title":"Cardioangiology"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0205","first-page":"1","article-title":"Diagnosis and management of hypertrophic cardiomyopathy","volume":"4","author":"Hamada","year":"2009","journal-title":"J Cardiol Jpn Ed"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0210","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.1002\/clc.20533","article-title":"Clinical features of the dilated phase of hypertrophic cardiomyopathy in comparison with those of dilated cardiomyopathy","volume":"33","author":"Hamada","year":"2010","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0215","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jjcc.2012.08.010","article-title":"Clinical characteristics and outcomes of dilated phase of hypertrophic cardiomyopathy: report from the registry data in Japan","volume":"61","author":"Goto","year":"2013","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0220","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.CIR.29.1.84","article-title":"Effects of beta adrenergic blockade on the circulation with particular reference to observations in patients with hypertrophic subaortic stenosis","volume":"29","author":"Harrison","year":"1964","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0225","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/bmj.1.5492.895","article-title":"Beta-adrenergic blockade in hypertrophic obstructive cardiomyopathy","volume":"1","author":"Cherian","year":"1966","journal-title":"Br Med J"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0230","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/hrt.32.6.804","article-title":"Long-term propranolol therapy in muscular subaortic stenosis","volume":"32","author":"Adelman","year":"1970","journal-title":"Br Heart J"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0235","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1056\/NEJM198703263161305","article-title":"Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1)","volume":"316","author":"Maron","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0240","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/clc.4960100106","article-title":"Comparative effects of calcium-channel blockers and beta-adrenergic blocker on early diastolic time intervals and A-wave ratio in patients with hypertrophic cardiomyopathy","volume":"10","author":"Doiuchi","year":"1987","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0245","first-page":"597","article-title":"Effect of propranolol on cardiac function and syncopal attack in patient with hypertrophic obstructive cardiomyopathy","volume":"14","author":"Sueda","year":"1984","journal-title":"J Cardiogr"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0250","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/hrt.42.1.35","article-title":"Treatment of hypertrophic obstructive cardiomyopathy with verapamil","volume":"42","author":"Kaltenbach","year":"1979","journal-title":"Br Heart J"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0255","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/0002-9149(80)90487-7","article-title":"Effect of verapamil on left ventricular isovolumic relaxation time and regional left ventricular filling in hypertrophic cardiomyopathy","volume":"45","author":"Hanrath","year":"1980","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0260","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/0002-9149(83)90317-X","article-title":"Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil","volume":"51","author":"Bonow","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0265","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/BF00054192","article-title":"Effect of disopyramide on left ventricular diastolic function in patients with hypertrophic cardiomyopathy: comparison with diltiazem","volume":"6","author":"Sumimoto","year":"1992","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0270","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1172\/JCI115061","article-title":"Diastolic dysfunction in hypertrophic cardiomyopathy. Effect on active force generation during systole","volume":"87","author":"Gwathmey","year":"1991","journal-title":"J Clin Invest"},{"issue":"Suppl. 1","key":"10.1016\/j.jjcc.2014.02.022_bib0275","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF00794070","article-title":"Molecular mechanisms regulating the myofilament response to Ca2+: implications of mutations causal for familial hypertrophic cardiomyopathy","volume":"92","author":"Palmiter","year":"1997","journal-title":"Basic Res Cardiol"},{"issue":"Suppl. 3","key":"10.1016\/j.jjcc.2014.02.022_bib0280","article-title":"Ia antiarrhythmic drugs for the treatment of hypertrophic cardiomyopathy","volume":"22","author":"Hamada","year":"2002","journal-title":"Jpn J Electrocardiol"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0285","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/01.CIR.66.2.447","article-title":"The cardiac effects of d- and l-disopyramide in normal subjects: a noninvasive study","volume":"66","author":"Pollick","year":"1982","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0290","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/01.CIR.97.1.41","article-title":"Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy","volume":"97","author":"Sherrid","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0295","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/0002-9149(88)90268-8","article-title":"Disopyramide in hypertrophic cardiomyopathy. I. Hemodynamic assessment after intravenous administration","volume":"62","author":"Pollick","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0300","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jacc.2005.01.012","article-title":"Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy","volume":"45","author":"Sherrid","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0305","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/j.1552-4604.1984.tb01834.x","article-title":"Single-dose pharmacokinetics and dose proportionality of oral cibenzoline","volume":"24","author":"Khoo","year":"1984","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0310","first-page":"841","article-title":"Cibenzoline relieves the pressure gradient of the left ventricular outflow tract stenosis with hypertrophic cardiomyopathy during bicycle ergometry","volume":"33","author":"Kondou","year":"2001","journal-title":"Shinzou"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0315","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s002280000136","article-title":"The relationship between risk of hypoglycemia and use of cibenzoline and disopyramide","volume":"56","author":"Takada","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0320","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1378\/chest.124.4.1275","article-title":"Diagnostic usefulness of carotid pulse tracing in patients with hypertrophic obstructive cardiomyopathy due to midventricular obstruction \u2013 a comparison with idiopathic hypertrophic subaortic stenosis","volume":"124","author":"Hamada","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0325","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1253\/circj.71.1540","article-title":"Effect of intravenous administration of cibenzoline on left ventricular diastolic pressures in patients with hypertrophic cardiomyopathy \u2013 its relationship to transmitral Doppler flow profiles","volume":"71","author":"Hamada","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0330","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0092-8674(00)81573-1","article-title":"A calcineurin-dependent transcription pathway for cardiac hypertrophy","volume":"93","author":"Molkentin","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0335","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1152\/physrev.1999.79.3.763","article-title":"Sodium\/calcium exchange: its physiological implications","volume":"79","author":"Blaustein","year":"1999","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0340","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/hh0901.090298","article-title":"Cardiac Na+\u2013Ca2+ exchange: molecular and pharmacological aspects","volume":"88","author":"Shigekawa","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2014.02.022_bib0345","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00424-003-1065-4","article-title":"The sodium\/calcium exchanger family-SLC8","volume":"447","author":"Quednau","year":"2004","journal-title":"Pfl\u00fcgers Arch"}],"updated-by":[{"DOI":"10.1016\/j.jjcc.2014.07.011","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000}}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S091450871400077X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S091450871400077X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T09:37:41Z","timestamp":1565343461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S091450871400077X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S091450871400077X"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2014.02.022","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jjcc.2014.07.011","asserted-by":"object"}]},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in medical treatment of hypertrophic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2014.02.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}